Core 3: Data Collection & Data Management Core

核心 3:数据收集

基本信息

项目摘要

SWAN-Aging is designed to determine the extent to which midlife health and characteristics of the menopause transition (MT) affect successful aging in women, including the rate of cognitive decline and the risk of dementia and disability. This application proposes to build upon the rich resources of the Study of Women’s Health Across the Nation (SWAN), a longitudinal cohort study initiated in 1994 to characterize the physiological and psychosocial changes that occur during the MT. In SWAN-Aging, we will extend follow-up of the SWAN cohort into early old age (66-75 years) and expand data collection to include additional domains of cognition to detect cognitive impairment (executive and visual-spatial function, language fluency) and the functional impact of cognitive deficits (cognitively demanding instrumental activities of daily living), cardiac health, and sedentary behavior. It is one of a few studies that can quantify the rate of decline in cognitive performance during midlife and early old age and determine the contribution of modifiable risk factors to the incidence of mild cognitive impairment. SWAN-Aging includes three integrated Projects: Project 1 will evaluate the impact of MT characteristics and midlife health indicators on preservation of cognitive function (avoiding cognitive decline and onset of mild cognitive impairment), sleep, genitourinary and sexual function, and quality of life in early old age; Project 2 will test how the MT relates to cardiac health and cardiovascular disease (CVD) events in women in early old age and test how cardiac health relates to early markers of physical impairment, Alzheimer’s disease, and vascular dementia at a critical period in the lifespan; and Project 3 will examine the role of MT and midlife characteristics on musculoskeletal health and physical functioning. The specific aims of Data Collection and Data Management Core (Core 3) are to: 1) Maintain excellent retention of study participants at all clinical sites; 2) Finalize the participant visit protocol and ensure the collection of high quality data from the clinical sites and reading centers; 3) Implement effective quality control measures and provide analytic datasets to study investigators; and 4) Archive and share the SWAN-Aging data. Core 3 will work with the clinical sites to employ effective strategies to maintain SWAN’s high participant retention rate and develop clear, detailed protocols, on-site personnel trainings and quality control measures to monitor the collection of data and specimens. Core 3 will build on the strengths of the existing SWAN data management structure and incorporate improved technology to improve the efficiency of quality control processes. Core 3 will construct datasets to facilitate a variety of analytic strategies to comprehensively assess the role of MT and midlife factors on cognitive decline, cardiac health and physical functioning and will archive de-identified datasets for public use. Core 3 will play a vital role in conducting the Projects by supporting retention and data collection and ensuring that study data will be high quality and used to identify modifiable factors linked to avoidance of mild cognitive impairment, preservation of functioning, and optimization of quality of life in early old age.
SWAN-Aging旨在确定中年健康和更年期过渡(MT)特征对女性成功衰老的影响程度,包括认知能力下降的速度以及痴呆和残疾的风险。这项申请建议建立在全国妇女健康研究(SWAN)的丰富资源的基础上,这是一项于1994年启动的纵向队列研究,旨在描述MT期间发生的生理和心理变化。在SWAN-Aging中,我们将SWAN队列的随访扩展到老年早期(66-75岁),并扩大数据收集范围,以包括其他认知领域,以检测认知障碍(执行和视觉空间功能,语言流畅性)和认知缺陷的功能影响(认知要求工具性日常生活活动),心脏健康和久坐行为。这是为数不多的几项研究之一,可以量化中年和老年早期认知能力的下降率,并确定可改变的风险因素对轻度认知障碍发生率的贡献。SWAN-Aging包括三个综合项目:项目1将评估MT特征和中年健康指标对认知功能保护的影响(避免认知能力下降和轻度认知障碍的发生)、睡眠、泌尿生殖和性功能以及老年早期的生活质量;项目2将测试MT如何与老年早期女性的心脏健康和心血管疾病(CVD)事件相关,并测试心脏健康如何与身体损伤的早期标志物相关,项目3将探讨MT和中年特征对肌肉骨骼健康和身体功能的作用。数据收集和数据管理核心(核心3)的具体目标是:1)在所有临床研究中心保持研究参与者的良好保留; 2)最终确定参与者访视方案,并确保从临床研究中心和阅读中心收集高质量数据; 3)实施有效的质量控制措施,并向研究者提供分析数据集;和4)存档和共享SWAN-Aging数据。核心3将与临床研究中心合作,采用有效的策略来维持SWAN的高受试者留存率,并制定明确、详细的方案、现场人员培训和质量控制措施,以监测数据和标本的收集。核心3将利用现有SWAN数据管理结构的优势,并采用改进的技术来提高质量控制流程的效率。核心3将构建数据集,以促进各种分析策略,全面评估MT和中年因素对认知能力下降,心脏健康和身体功能的作用,并将存档去识别数据集供公众使用。核心3将通过支持保留和数据收集并确保研究数据的高质量,并用于识别与避免轻度认知障碍、功能保留和优化老年早期生活质量相关的可修改因素,在开展项目中发挥至关重要的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Maria Mori Brooks其他文献

ORBITA revisited: what it really means and what it does not?
重新审视 ORBITA:它的真正含义是什么,不是什么?
  • DOI:
    10.1093/eurheartj/ehx796
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    39.3
  • 作者:
    B. Chaitman;Maria Mori Brooks;K. Fox;T. Lüscher
  • 通讯作者:
    T. Lüscher
Relationships between substance use treatment facilities and alcohol-attributable mortality across U.S. counties
美国各县药物使用治疗机构与酒精归因死亡率之间的关系
  • DOI:
    10.1016/j.addbeh.2025.108364
  • 发表时间:
    2025-09-01
  • 期刊:
  • 影响因子:
    3.600
  • 作者:
    Natalie Sumetsky;Maria Mori Brooks;Jeanine Buchanich;Brooke S.G. Molina;Christina Mair
  • 通讯作者:
    Christina Mair
CULTURING BLASTOCYSTS TO DAY 7 OF DEVELOPMENT YIELDS DECREASED ODDS OF LIVE BIRTH FOLLOWING EUPLOID FROZEN EMBRYO TRANSFER
  • DOI:
    10.1016/j.fertnstert.2024.07.886
  • 发表时间:
    2024-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Belita Opene;Nicole M. Fischer;Alexandra A. Szczupak;Roy G. Handelsman;Julie M. Rios;Maria Mori Brooks;Jiaxuan Duan;Bernadette Paternoster;G. David Ball;Pamela B. Parker;Melissa Lombardozzi
  • 通讯作者:
    Melissa Lombardozzi

Maria Mori Brooks的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Maria Mori Brooks', 18)}}的其他基金

Core 3: Data Collection & Data Management Core
核心 3:数据收集
  • 批准号:
    10471455
  • 财政年份:
    2020
  • 资助金额:
    $ 429.92万
  • 项目类别:
Core 1: Administrative Core
核心 1:行政核心
  • 批准号:
    10471453
  • 财政年份:
    2020
  • 资助金额:
    $ 429.92万
  • 项目类别:
The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age
全国妇女健康研究 (SWAN):中年和更年期过渡对早年健康和功能的影响
  • 批准号:
    10911525
  • 财政年份:
    2020
  • 资助金额:
    $ 429.92万
  • 项目类别:
Core 1: Administrative Core
核心 1:行政核心
  • 批准号:
    10263895
  • 财政年份:
    2020
  • 资助金额:
    $ 429.92万
  • 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
  • 批准号:
    10402934
  • 财政年份:
    2019
  • 资助金额:
    $ 429.92万
  • 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
  • 批准号:
    10163253
  • 财政年份:
    2019
  • 资助金额:
    $ 429.92万
  • 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
  • 批准号:
    9926916
  • 财政年份:
    2019
  • 资助金额:
    $ 429.92万
  • 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
  • 批准号:
    10642928
  • 财政年份:
    2019
  • 资助金额:
    $ 429.92万
  • 项目类别:
Myocardial Ischemia and Transfusion (MINT) - DCC
心肌缺血和输血 (MINT) - DCC
  • 批准号:
    10290738
  • 财政年份:
    2016
  • 资助金额:
    $ 429.92万
  • 项目类别:
Treatment and Risk Factor Determinants of Cardiovascular Outcomes in BARI 2D
BARI 2D 心血管结局的治疗和危险因素决定因素
  • 批准号:
    8625130
  • 财政年份:
    2013
  • 资助金额:
    $ 429.92万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 429.92万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 429.92万
  • 项目类别:
    Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 429.92万
  • 项目类别:
    Operating Grants
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 429.92万
  • 项目类别:
    Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 429.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 429.92万
  • 项目类别:
    Studentship
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 429.92万
  • 项目类别:
    Fellowship Award
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 429.92万
  • 项目类别:
    Standard Grant
McGill-MOBILHUB: Mobilization Hub for Knowledge, Education, and Artificial Intelligence/Deep Learning on Brain Health and Cognitive Impairment in Aging.
McGill-MOBILHUB:脑健康和衰老认知障碍的知识、教育和人工智能/深度学习动员中心。
  • 批准号:
    498278
  • 财政年份:
    2024
  • 资助金额:
    $ 429.92万
  • 项目类别:
    Operating Grants
Welfare Enhancing Fiscal and Monetary Policies for Aging Societies
促进老龄化社会福利的财政和货币政策
  • 批准号:
    24K04938
  • 财政年份:
    2024
  • 资助金额:
    $ 429.92万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了